OCUPHIRE PHARMA, INC. INDEMNITY AGREEMENTIndemnity Agreement • November 6th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnity Agreement (this “Agreement”) is made and entered into as of _______________, by and between Ocuphire Pharma, Inc. a Delaware corporation (the “Company”), and [Insert Name] (“Indemnitee”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • November 6th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of November 5, 2020 (this “Agreement”), is entered into by and among Rexahn Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as representative of the Holders (the “CVR Representative”), and Olde Monmouth Stock Transfer Co., Inc., as Rights Agent.
